Utah Begin Period Cash Flow vs Change Receivables Analysis

UTMD Stock

USD 63.84 0.10 0.16%

Utah Medical financial indicator trend analysis is much more than just breaking down Utah Medical Products prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Utah Medical Products is a good investment. Please check the relationship between Utah Medical Begin Period Cash Flow and its Change Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Begin Period Cash Flow vs Change Receivables

Begin Period Cash Flow vs Change Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Utah Medical Products Begin Period Cash Flow account and Change Receivables. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Utah Medical's Begin Period Cash Flow and Change Receivables is -0.18. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Change Receivables in the same time period over historical financial statements of Utah Medical Products, assuming nothing else is changed. The correlation between historical values of Utah Medical's Begin Period Cash Flow and Change Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Utah Medical Products are associated (or correlated) with its Change Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change Receivables has no effect on the direction of Begin Period Cash Flow i.e., Utah Medical's Begin Period Cash Flow and Change Receivables go up and down completely randomly.

Correlation Coefficient

-0.18

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Change Receivables

The difference in the amount of accounts receivable from one accounting period to the next. A positive number indicates an increase in receivables, while a negative number indicates a decrease.

Most indicators from Utah Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Utah Medical Products current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

The current year's Enterprise Value is expected to grow to about 202 M, whereas Selling General Administrative is forecasted to decline to about 6.9 M.

	2021	2022	2023	2024 (projected)
Gross Profit	30.9M	32.2M	30.0M	20.6M
Total Revenue	49.1M	52.3M	50.2M	36.6M

Gross Profit Total Revenue

Utah Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Accounts Payable	Short Term Debt	Common Stock Total Equity	Common Stock
Total Assets		-0.31	0.53	0.05	0.97	0.83	-0.83	0.96	0.88	0.19	0.02	0.88	0.6	-0.66	-0.23	0.95	0.02	-0.81	-0.12	0.79	0.9	-0.24	-0.18	-0.35	-0.83	-0.83
Short Long Term Debt Total	-0.31		-0.3	0.79	-0.52	-0.22	0.7	-0.53	-0.56	0.52	-0.07	-0.56	0.18	-0.12	0.95	-0.29	0.52	0.15	0.95	-0.34	-0.54	0.69	0.07	0.93	-0.06	-0.06
Other Current Liab	0.53	-0.3		-0.18	0.53	0.63	-0.61	0.58	0.61	-0.19	0.08	0.61	0.12	-0.24	-0.15	0.53	-0.51	-0.69	-0.16	0.48	0.61	-0.48	-0.58	-0.51	-0.3	-0.3
Total Current Liabilities	0.05	0.79	-0.18		-0.17	0.11	0.4	-0.2	-0.29	0.67	-0.04	-0.29	0.5	-0.48	0.79	0.01	0.68	-0.06	0.89	-0.14	-0.25	0.71	0.36	0.86	-0.44	-0.43
Total Stockholder Equity	0.97	-0.52	0.53	-0.17		0.77	-0.93	1.0	0.94	0.0	0.03	0.94	0.48	-0.52	-0.45	0.94	-0.13	-0.75	-0.36	0.81	0.95	-0.41	-0.2	-0.55	-0.71	-0.71
Property Plant And Equipment Net	0.83	-0.22	0.63	0.11	0.77		-0.58	0.79	0.59	0.45	0.01	0.59	0.56	-0.82	-0.02	0.67	0.07	-0.93	0.02	0.47	0.62	0.0	-0.29	-0.29	-0.83	-0.83
Net Debt	-0.83	0.7	-0.61	0.4	-0.93	-0.58		-0.93	-0.98	0.36	-0.01	-0.98	-0.19	0.23	0.67	-0.86	0.39	0.58	0.59	-0.85	-0.98	0.71	0.31	0.73	0.44	0.44
Retained Earnings	0.96	-0.53	0.58	-0.2	1.0	0.79	-0.93		0.94	0.0	0.05	0.94	0.46	-0.53	-0.46	0.93	-0.14	-0.79	-0.37	0.8	0.95	-0.42	-0.24	-0.58	-0.71	-0.71
Cash	0.88	-0.56	0.61	-0.29	0.94	0.59	-0.98	0.94		-0.3	-0.01	1.0	0.26	-0.26	-0.55	0.92	-0.33	-0.61	-0.46	0.89	1.0	-0.66	-0.33	-0.62	-0.51	-0.51
Non Current Assets Total	0.19	0.52	-0.19	0.67	0.0	0.45	0.36	0.0	-0.3		0.04	-0.3	0.64	-0.78	0.66	-0.01	0.69	-0.37	0.68	-0.28	-0.26	0.86	0.29	0.54	-0.61	-0.61
Non Currrent Assets Other	0.02	-0.07	0.08	-0.04	0.03	0.01	-0.01	0.05	-0.01	0.04		-0.01	0.08	-0.02	-0.05	0.03	-0.01	-0.11	-0.05	-0.08	0.0	0.08	-0.02	-0.08	0.01	0.01
Cash And Short Term Investments	0.88	-0.56	0.61	-0.29	0.94	0.59	-0.98	0.94	1.0	-0.3	-0.01		0.26	-0.26	-0.55	0.92	-0.33	-0.61	-0.46	0.89	1.0	-0.66	-0.33	-0.62	-0.51	-0.51
Net Receivables	0.6	0.18	0.12	0.5	0.48	0.56	-0.19	0.46	0.26	0.64	0.08	0.26		-0.74	0.28	0.49	0.46	-0.53	0.37	0.37	0.31	0.38	0.26	0.19	-0.71	-0.71
Common Stock Shares Outstanding	-0.66	-0.12	-0.24	-0.48	-0.52	-0.82	0.23	-0.53	-0.26	-0.78	-0.02	-0.26	-0.74		-0.3	-0.47	-0.58	0.75	-0.36	-0.23	-0.3	-0.48	-0.14	-0.11	0.92	0.92
Non Current Liabilities Total	-0.23	0.95	-0.15	0.79	-0.45	-0.02	0.67	-0.46	-0.55	0.66	-0.05	-0.55	0.28	-0.3		-0.27	0.51	-0.01	0.98	-0.38	-0.52	0.75	0.04	0.85	-0.19	-0.18
Inventory	0.95	-0.29	0.53	0.01	0.94	0.67	-0.86	0.93	0.92	-0.01	0.03	0.92	0.49	-0.47	-0.27		-0.07	-0.7	-0.16	0.87	0.94	-0.4	-0.23	-0.35	-0.71	-0.71
Other Current Assets	0.02	0.52	-0.51	0.68	-0.13	0.07	0.39	-0.14	-0.33	0.69	-0.01	-0.33	0.46	-0.58	0.51	-0.07		-0.05	0.58	-0.18	-0.29	0.8	0.51	0.62	-0.49	-0.49
Other Stockholder Equity	-0.81	0.15	-0.69	-0.06	-0.75	-0.93	0.58	-0.79	-0.61	-0.37	-0.11	-0.61	-0.53	0.75	-0.01	-0.7	-0.05		-0.04	-0.47	-0.63	0.03	0.41	0.31	0.8	0.8
Total Liab	-0.12	0.95	-0.16	0.89	-0.36	0.02	0.59	-0.37	-0.46	0.68	-0.05	-0.46	0.37	-0.36	0.98	-0.16	0.58	-0.04		-0.29	-0.43	0.75	0.14	0.88	-0.29	-0.29
Property Plant And Equipment Gross	0.79	-0.34	0.48	-0.14	0.81	0.47	-0.85	0.8	0.89	-0.28	-0.08	0.89	0.37	-0.23	-0.38	0.87	-0.18	-0.47	-0.29		0.9	-0.59	-0.3	-0.4	-0.45	-0.46
Total Current Assets	0.9	-0.54	0.61	-0.25	0.95	0.62	-0.98	0.95	1.0	-0.26	0.0	1.0	0.31	-0.3	-0.52	0.94	-0.29	-0.63	-0.43	0.9		-0.62	-0.31	-0.59	-0.55	-0.55
Intangible Assets	-0.24	0.69	-0.48	0.71	-0.41	0.0	0.71	-0.42	-0.66	0.86	0.08	-0.66	0.38	-0.48	0.75	-0.4	0.8	0.03	0.75	-0.59	-0.62		0.47	0.75	-0.28	-0.28
Accounts Payable	-0.18	0.07	-0.58	0.36	-0.2	-0.29	0.31	-0.24	-0.33	0.29	-0.02	-0.33	0.26	-0.14	0.04	-0.23	0.51	0.41	0.14	-0.3	-0.31	0.47		0.32	-0.07	-0.07
Short Term Debt	-0.35	0.93	-0.51	0.86	-0.55	-0.29	0.73	-0.58	-0.62	0.54	-0.08	-0.62	0.19	-0.11	0.85	-0.35	0.62	0.31	0.88	-0.4	-0.59	0.75	0.32		-0.03	-0.03
Common Stock Total Equity	-0.83	-0.06	-0.3	-0.44	-0.71	-0.83	0.44	-0.71	-0.51	-0.61	0.01	-0.51	-0.71	0.92	-0.19	-0.71	-0.49	0.8	-0.29	-0.45	-0.55	-0.28	-0.07	-0.03		1.0
Common Stock	-0.83	-0.06	-0.3	-0.43	-0.71	-0.83	0.44	-0.71	-0.51	-0.61	0.01	-0.51	-0.71	0.92	-0.18	-0.71	-0.49	0.8	-0.29	-0.46	-0.55	-0.28	-0.07	-0.03	1.0

Click cells to compare fundamentals

Utah Medical Account Relationship Matchups

Utah Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	109.8M	111.7M	115.6M	123.9M	135.5M	142.2M
Other Current Liab	2.4M	2.9M	2.7M	4.3M	3.6M	2.6M
Total Current Liabilities	3.4M	3.8M	3.6M	5.8M	4.7M	4.6M
Total Stockholder Equity	101.1M	102.8M	107.1M	114.3M	128.3M	134.7M
Property Plant And Equipment Net	10.7M	11.3M	11.0M	10.6M	10.6M	9.6M
Net Debt	(42.4M)	(51.3M)	(60.6M)	(74.7M)	(92.6M)	(87.9M)
Retained Earnings	110.8M	111.0M	115.3M	126.0M	138.3M	145.3M
Cash	42.8M	51.6M	61.0M	75.1M	92.9M	97.5M
Non Current Assets Total	54.9M	49.5M	42.4M	34.0M	29.2M	27.1M
Non Currrent Assets Other	54.9M	(49.5M)	(2.1M)	(1.5M)	(1.0)	(0.95)
Cash And Short Term Investments	42.8M	51.6M	61.0M	75.1M	92.9M	97.5M
Net Receivables	4.7M	4.1M	5.1M	5.5M	3.3M	4.5M
Common Stock Shares Outstanding	3.7M	3.7M	3.7M	3.6M	3.6M	5.0M
Liabilities And Stockholders Equity	109.8M	111.7M	115.6M	123.9M	135.5M	142.2M
Non Current Liabilities Total	5.2M	5.1M	4.8M	3.9M	2.4M	2.3M
Inventory	6.9M	6.2M	6.6M	8.8M	9.6M	10.1M
Other Current Assets	443K	346K	456K	515K	481K	457.0K
Other Stockholder Equity	17K	115K	841K	251K	594.0K	564.3K
Total Liab	8.7M	8.9M	8.4M	9.6M	7.1M	9.7M
Property Plant And Equipment Gross	10.7M	11.3M	33.9M	33.2M	34.3M	36.0M
Total Current Assets	54.9M	62.3M	73.2M	89.9M	106.3M	111.6M
Accumulated Other Comprehensive Income	(9.8M)	(8.3M)	(9.1M)	(12.0M)	(10.7M)	(10.1M)
Intangible Assets	30.2M	24.0M	17.3M	10.4M	4.9M	4.7M
Accounts Payable	1.1M	788K	761K	1.2M	769K	1.3M
Property Plant Equipment	10.7M	11.3M	11.0M	10.2M	11.8M	10.1M
Good Will	14.0M	14.2M	14.1M	13.4M	13.7M	13.0M
Other Liab	4.9M	4.8M	4.5M	3.3M	3.8M	4.9M
Net Tangible Assets	56.9M	64.7M	75.7M	90.5M	104.1M	62.4M
Retained Earnings Total Equity	110.8M	111.0M	115.3M	126.0M	144.9M	93.3M
Capital Surpluse	18K	115K	841K	251K	225.9K	214.6K
Deferred Long Term Liab	521K	651K	577K	549K	494.1K	356.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
WD	Walker Dunlop

When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports:

How To Invest In Utah

Details

Is Utah Stock a good investment?

Details

What is Utah Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

1.2

Earnings Share

4.28

Revenue Per Share

12.392

Quarterly Revenue Growth

(0.20)

The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Utah Begin Period Cash Flow vs Change Receivables Analysis

Begin Period Cash Flow vs Change Receivables

Begin Period Cash Flow vs Change Receivables Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Change Receivables

Utah Medical fundamental ratios Correlations

Utah Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Utah Medical fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.98	Non Current Liabilities Total

Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Retained Earnings	- 0.93	Net Debt
Other Stockholder Equity	- 0.93	Property Plant And Equipment Net
Net Debt	- 0.93	Total Stockholder Equity